These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37336551)

  • 21. Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients.
    Ciccarese G; Di Biagio A; Bruzzone B; Guadagno A; Taramasso L; Oddenino G; Brucci G; Labate L; De Pace V; Mastrolonardo M; Broccolo F; Robello G; Drago F; Bassetti M; Parodi A
    J Med Virol; 2023 Feb; 95(2):e28560. PubMed ID: 36757085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks.
    Li P; Li J; Ayada I; Avan A; Zheng Q; Peppelenbosch MP; de Vries AC; Pan Q
    J Infect Dis; 2023 Aug; 228(4):391-401. PubMed ID: 36735342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mpox - Formerly Monkey Pox - in Dermatology: A Review of Epidemiologic Features, Clinical Presentation, Diagnosis, and Treatment.
    Català A; Riera J; Fuertes I
    Actas Dermosifiliogr; 2023 Apr; 114(4):318-326. PubMed ID: 36682683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A global update of mpox (monkeypox) in children.
    Sam-Agudu NA; Martyn-Dickens C; Ewa AU
    Curr Opin Pediatr; 2023 Apr; 35(2):193-200. PubMed ID: 36809304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mpox: an updated review of dermatological manifestations in the current outbreak.
    Maronese CA; Avallone G; Aromolo IF; Spigariolo CB; Quattri E; Ramoni S; Carrera CG; Marzano AV
    Br J Dermatol; 2023 Aug; 189(3):260-270. PubMed ID: 37146166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022.
    Siegenbeek van Heukelom ML; Jongen VW; Schouten J; Hoornenborg E; Bruisten S; Westerhuis B; Welkers MR; Vergunst CE; Prins M; Schim van der Loeff MF; de Vries HJC
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1891-1896. PubMed ID: 37212540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mpox outbreak in France: epidemiological characteristics and sexual behaviour of cases aged 15 years or older, 2022.
    Krug C; Tarantola A; Chazelle E; Fougère E; Velter A; Guinard A; Souares Y; Mercier A; François C; Hamdad K; Tan-Lhernould L; Balestier A; Lahbib H; Etien N; Bernillon P; De Lauzun V; Durand J; Fayad M; ; De Valk H; Beck F; Che D; Coignard B; Lot F; Mailles A;
    Euro Surveill; 2023 Dec; 28(50):. PubMed ID: 38099346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisite Mpox Infection and Viral Dynamics Among Persons With HIV in Metro Atlanta.
    Damhorst GL; Fujita AW; Fitts E; Szabo B; Bowers HB; Sabino C; Ahmed A; Wang E; Piantadosi A; McLendon K; Sullivan J; Greenleaf M; McCaslin D; Palmore M; Anderson AM; Aldred B; Gunthel C; Martin GS; Colasanti JA; Lam WA; Bassit L; Rao A; Sheth AN; Titanji BK
    J Infect Dis; 2024 Mar; 229(Supplement_2):S213-S218. PubMed ID: 38019187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
    Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
    Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration.
    Lucero-Obusan C; Oda G; Schirmer P; Edson C; Trevino C; Elbeik T; Holodniy M
    J Infect Dis; 2024 Mar; 229(Supplement_2):S172-S180. PubMed ID: 38134309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of pain and stigma experiences in people diagnosed with mpox in Baltimore, Maryland during 2022 global outbreak.
    Schmalzle SA; Grant M; Lovelace S; Jung J; Choate C; Guerin J; Weinstein W; Taylor G
    PLoS One; 2024; 19(5):e0299587. PubMed ID: 38771788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Mpox in People Living with HIV: Epidemiologic and Clinical Perspectives from Nigeria.
    Iroezindu MO; Crowell TA; Ogoina D; Yinka-Ogunleye A
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):593-600. PubMed ID: 37646422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing mpox at a Frontline Community Health Center: Lessons for the Next Outbreak.
    Allan-Blitz LT; Khan T; Elangovan K; Smith K; Multani A; Mayer KH
    Public Health Rep; 2024; 139(3):294-300. PubMed ID: 37846528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic dilemma for atypical presentation of progressive human Mpox.
    Sahra S; Villalobos RO; Scott BM; Bowman DJ; Sassine J; Salvaggio M; Drevets DA; Higuita NIA
    BMC Infect Dis; 2023 Dec; 23(1):850. PubMed ID: 38053027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021-2022.
    Doyle TJ; Gumke M; Stanek D; Moore J; Buck B; Locksmith T; Tomson K; Schmedes S; Churchwell G; Hubsmith SJ; Krishnamoorthy B; Poschman K; Danforth B; Chacreton D;
    Emerg Infect Dis; 2024 Apr; 30(4):633-43. PubMed ID: 38526187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Epidemiological Characteristics of Mpox in HIV-Infected and Uninfected Men Who Have Sex with Men: A Retrospective Study in Lisbon.
    de Sousa D; Volovetska Y; Nunes D; Lemos C; Borges-Costa J; Filipe P
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38400001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.